Honorary Fellows are elected for life by the British Pharmacological Society in recognition of sustained excellence and leadership in science, healthcare, and public service.
The Honorary Fellowship includes Nobel Laureates, international prize-winners, long-standing members of the Society, and those who have advanced the disciplines of Pharmacology, Clinical Pharmacology and Therapeutics through research, leadership and contribution to the British Pharmacological Society.
Find out more and nominate individuals for Honorary Fellowship.
This Directory has been created to increase the visibility of our Honorary Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Honorary Fellows with similar areas of interest.
Here you can find profiles of each Honorary Fellow, including information on their institutional affiliation, year elected, primary professional setting, Affinity Group membership, along with a short biography.
Please click the magnifying glass icon to begin any searches.
Professor Emeritus, The University of Manchester; previously Leech Professor of Pharmacology, Manchester, 1989 - 2011.
I have been a member of the BPS since 1976 and have spent my career in the Pharmaceutical industry, initially in the UK at Beecham Research Laboratories and Syntex Research Scotland.
I am Emeritus Professor of Applied Pharmacology at the William Harvey Research Institute, Barts and the School of Medicine, and Visiting Professor for the University of Hertfordshire and the University of Tampere, Finland.
Professor Chris Whitty is England’s Chief Medical Officer (CMO) and the UK Government’s Chief Medical Adviser.
Timothy John Williams was born in Gloucester in 1945 and attended the local Sir Thomas Rich’s Grammar School.
Professor Emeritus, The University of Bath; previously Professor of Neuroscience in the Department of Biology & Biochemistry, Bath 2000-2021.
Sir Kent Woods was the Director of the NHS Health Technology Assessment Programme 1999-2003, Chief Executive of the Medicines and Healthcare Products Regulatory Agency (MHRA) 2004-2013 and Chairman of the Management Board of the European Medicines Agency 2011-2015.